117 related articles for article (PubMed ID: 35171058)
1. Early death in supraglottic laryngeal squamous cell carcinoma: A population-based study.
Liu J; Sun Q; Zhao J; Qin X; Gao T; Bai G; Chen G; Guo Z
Ear Nose Throat J; 2022 Feb; ():1455613221078184. PubMed ID: 35171058
[TBL] [Abstract][Full Text] [Related]
2. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
4. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and survival outcomes of laryngeal squamous cell carcinoma patients with lung metastasis: A population-based study.
Yang W; Mei X; Zhou Y; Su R; Lei W; Zheng S; Zhu R; Guo L; Tao Y; Su Y; Li J; Ding C; Zou S; Li X; Hu H
Auris Nasus Larynx; 2021 Aug; 48(4):723-730. PubMed ID: 33358379
[TBL] [Abstract][Full Text] [Related]
6. Supraglottic Squamous Cell Carcinoma: A Population-Based Study of 22,675 Cases.
Patel TD; Echanique KA; Yip C; Hsueh WD; Baredes S; Park RCW; Eloy JA
Laryngoscope; 2019 Aug; 129(8):1822-1827. PubMed ID: 30536822
[TBL] [Abstract][Full Text] [Related]
7. The minimal number of examined lymph nodes for accurate nodal staging and favorable prognosis in T1-2 supraglottic laryngeal squamous cell carcinoma.
Zhuge L; Wang S; Huang Z; Cai H; Li Z
Eur J Surg Oncol; 2023 Oct; 49(10):107041. PubMed ID: 37633174
[TBL] [Abstract][Full Text] [Related]
8. Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center.
Brandstorp-Boesen J; Falk RS; Boysen M; Brøndbo K
Eur Arch Otorhinolaryngol; 2014 Dec; 271(12):3233-9. PubMed ID: 24871863
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of microRNA-21 and microRNA-10a can predict long-term prognosis in laryngeal cancer patients: a multicenter study.
Gao S; Xu Q; Zhou Y; Yi Q
Transl Cancer Res; 2020 May; 9(5):3680-3690. PubMed ID: 35117730
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression and its detection in human supraglottic laryngeal squamous cell carcinoma.
Sun X; Song Y; Tai X; Liu B; Ji W
Biomed Rep; 2013 Sep; 1(5):743-746. PubMed ID: 24649021
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy vs radiotherapy for non-surgical locally advanced laryngeal squamous cell carcinoma patients: a propensity score-matched study and practical nomogram construction.
Zhang Y; Wang Z; Zheng Y
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1449-1456. PubMed ID: 38158418
[TBL] [Abstract][Full Text] [Related]
12. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analysis of prognostic factors in patients with lip squamous cell carcinoma after surgery.
Cheng H; Xu JH; He JQ; Yang XY; Shen XN; Xu XL
World J Surg Oncol; 2024 Jan; 22(1):35. PubMed ID: 38279138
[TBL] [Abstract][Full Text] [Related]
14. Treatment and outcome among patients with laryngeal squamous cell carcinoma in Stockholm-A population-based study.
Blomkvist R; Marklund L; Hammarstedt-Nordenvall L; Gottlieb-Vedi E; Mäkitie A; Palmgren B
Laryngoscope Investig Otolaryngol; 2023 Apr; 8(2):441-449. PubMed ID: 37090883
[TBL] [Abstract][Full Text] [Related]
15. A deep learning-based model predicts survival for patients with laryngeal squamous cell carcinoma: a large population-based study.
Liao F; Wang W; Wang J
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):789-795. PubMed ID: 36030468
[TBL] [Abstract][Full Text] [Related]
16. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
[TBL] [Abstract][Full Text] [Related]
17. A Predictive Nomogram for Lymph Node Metastasis in Supraglottic Laryngeal Squamous Cell Carcinoma.
Song L; Heng Y; Hsueh CY; Huang H; Tao L; Zhou L; Zhang M
Front Oncol; 2022; 12():786207. PubMed ID: 35311100
[TBL] [Abstract][Full Text] [Related]
18. Comparison of treatment modalities for selected advanced laryngeal squamous cell carcinoma.
Wushouer A; Li W; Zhang M; Lei D; Pan X
Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):361-371. PubMed ID: 33864482
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis revealing genome-wide chromosomal copy number variation in supraglottic laryngeal squamous cell carcinoma.
Li D; Wang X; Lu S; Wang P; Wang X; Yin W; Zhu W; Li S
Oncol Lett; 2020 Aug; 20(2):1201-1212. PubMed ID: 32724360
[TBL] [Abstract][Full Text] [Related]
20. Value of routine follow-up for recurrence detection after treatment with curative intent for laryngeal squamous cell carcinoma.
van de Weerd C; Geurts SME; Vercoulen RJMT; van Veggel IHF; Brands MT; Marres HAM; Hermens RPMG; van Tol-Geerdink JJ; Kaanders JHAM; Takes RP
Eur J Surg Oncol; 2024 Jan; 50(1):107304. PubMed ID: 38043360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
